<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01289392</url>
  </required_header>
  <id_info>
    <org_study_id>CEP 0352/09</org_study_id>
    <nct_id>NCT01289392</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure (CPAP), Oral Appliance and Physical Exercise in the Obstructive Sleep Apnea</brief_title>
  <official_title>Effects of the Treatment With Continuous Positive Airway Pressure (CPAP) and Oral Appliance, Associated or Not Associated With Physical Exercise, in the Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Associação Fundo de Incentivo à Pesquisa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Associação Fundo de Incentivo à Pesquisa</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: It is unclear whether exercise training with or without Continuous Positive
      Airway Pressure (CPAP) and Oral Appliance (OA) is more effective in reducing symptoms of
      Obstructive Sleep Apnea (OSA) than treatment solely with CPAP or OA.

      Objective: In patients with moderate OSA, the investigators will evaluate the effect on the
      subjective and objective measures of sleep, quality of life and mood of different forms of
      treatment: exercise training of 4 months; exercise training of 4 months associated with CPAP
      and OA; treatment with CPAP and treatment with OA.

      Material and Methods: Sixty male patients (25-65 years, sedentary lifestyle, Body Mass Index
      (BMI) &lt; 35kg/m2, Apnea-Hypopnea Index (AHI) between 15-30/h, Epworth sleepiness scale &gt; 9)
      will be divided into three groups: CPAP+exercise group (CE; n=20), OA+exercise group (AE;
      n=20), and Exercise training group (E; n=20). The patients in groups CE and AE will complete
      two months of treatment with CPAP or OA to examine the separate effects of these devices. As
      the patients of the E group did not use the CPAP but will undergo four months of exercise
      training. After this initial step, patients in CE and AE groups will undergo four months of
      exercise training associated with CPAP or OA. The investigators will evaluate the subjective
      sleep parameters (sleep disorders questionnaire, the Epworth Sleepiness Scale, sleep diaries)
      and objective (polysomnography), Short Form Health Survey (SF-36), Questionnaire Profile of
      Mood States (POMS) and anthropometric measurements (neck circumference and body composition),
      the incremental exercise test (ergospirometry) and the one Repetition Maximum test (1RM).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Objective Sleep Parameters</measure>
    <time_frame>6 months after the basal evaluation</time_frame>
    <description>Polysomnographic date of sleep stages percentages, sleep efficiency, arousals, apnea-hypopnea index, oxyhemoglobin saturation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sleep Apnea</measure>
    <time_frame>6 months</time_frame>
    <description>Number of events per hour of sleep</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inflammatory Markers</measure>
    <time_frame>6 months after the basal evaluation</time_frame>
    <description>Blood samples to test: tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP), Interleukin-6 and Interleukin-8</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Continuous Positive Airway Pressure (CPAP)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CPAP is the gold standard treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oral Appliance</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Alternative treatment for obstructive sleep apnea patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Physical Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Aerobic and resistance physical exercises</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Positive Airway Pressure (CPAP)</intervention_name>
    <description>Previously determinated airway pressure: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
    <arm_group_label>Continuous Positive Airway Pressure (CPAP)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Oral Appliance (OA)</intervention_name>
    <description>Anterior mandibular repositioner: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
    <arm_group_label>Oral Appliance</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physical Exercise</intervention_name>
    <description>aerobic and resistance Physical exercise, three times a week, for four months</description>
    <arm_group_label>Physical Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male subjects aged between 25 and 65 years old

          -  Sedentary according to the criteria of Godin and Shephard (1985) and / or ACSM (2000)

          -  Epworth Sleepiness Scale over score of nine

          -  Normal range of laboratory tests [blood count, cholesterol, High-density lipoprotein
             (HDL), triglycerides, fasting glucose, creatinine, Thyroid-stimulating hormone (TSH)]

          -  Lung function test (spirometry), chest X-ray (for smokers and former smokers)
             electrocardiogram (rest and stress) and ENT examination without significant changes

        Exclusion Criteria:

          -  Presence of clinical diseases (chronic obstructive pulmonary disease, asthma,
             interstitial lung diseases, neuromuscular diseases, heart failure, thyroid disease,
             rheumatologic and psychiatric) and other sleep disorders

          -  Presence of anatomical obstructive upper airway, tonsil grade III and IV septal
             deviation and grade III (severe) that may affect the outcome of CPAP

          -  Loss of posterior dental support to undermine the retention of oral appliance

          -  Active periodontal disease, compared Dental crown / dental root less than or equal to
             1 (c / r ≤ 1), need for primary dental care (cavities, root canal treatment or
             retreatment, dentures, ie outlying), open bite

          -  Protrusive displacement less than five millimeters

          -  Limited mouth opening (would prevent the forming of the dental arches)

          -  Alcoholism

          -  Uuse of sleep-inducing medications

          -  Habits or occupations that lead to sleep deprivation or alteration of the sleep-wake
             cycle

          -  Inability to perform physical exercise, regular history sports activities

          -  Intolerance to Continuous Positive Airway Pressure (CPAP)

          -  Obesity grade II (moderate) and III (severe)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Instituto do Sono/Associação Fundo de Incentivo a Psicofarmacologia</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <zip>04024-002</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2011</study_first_submitted>
  <study_first_submitted_qc>February 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2011</study_first_posted>
  <results_first_submitted>January 28, 2013</results_first_submitted>
  <results_first_submitted_qc>March 4, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 12, 2013</results_first_posted>
  <last_update_submitted>April 25, 2013</last_update_submitted>
  <last_update_submitted_qc>April 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Associação Fundo de Incentivo à Pesquisa</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Lia Azeredo-Bittencourt</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea</keyword>
  <keyword>CPAP</keyword>
  <keyword>Oral appliance</keyword>
  <keyword>Aerobic exercise</keyword>
  <keyword>Resistance training</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>sleep disorder clinic</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Continuous Positive Airway Pressure (CPAP)</title>
          <description>CPAP is the gold standard treatment
Continuous Positive Airway Pressure (CPAP) : Previously determinated airway pressure: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
        </group>
        <group group_id="P2">
          <title>Oral Appliance</title>
          <description>Alternative treatment for obstructive sleep apnea patients
Oral Appliance (OA) : Anterior mandibular repositioner: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
        </group>
        <group group_id="P3">
          <title>Physical Exercise</title>
          <description>Aerobic and resistance physical exercises
Physical Exercise : aerobic and resistance Physical exercise, three times a week, for four months</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Continuous Positive Airway Pressure (CPAP)</title>
          <description>CPAP is the gold standard treatment
Continuous Positive Airway Pressure (CPAP) : Previously determinated airway pressure: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
        </group>
        <group group_id="B2">
          <title>Oral Appliance</title>
          <description>Alternative treatment for obstructive sleep apnea patients
Oral Appliance (OA) : Anterior mandibular repositioner: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
        </group>
        <group group_id="B3">
          <title>Physical Exercise</title>
          <description>Aerobic and resistance physical exercises
Physical Exercise : aerobic and resistance Physical exercise, three times a week, for four months</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="9"/>
            <count group_id="B2" value="9"/>
            <count group_id="B3" value="7"/>
            <count group_id="B4" value="25"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.62" spread="8.15"/>
                    <measurement group_id="B2" value="42.33" spread="6.20"/>
                    <measurement group_id="B3" value="42.28" spread="8.28"/>
                    <measurement group_id="B4" value="41.10" spread="7.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Objective Sleep Parameters</title>
        <description>Polysomnographic date of sleep stages percentages, sleep efficiency, arousals, apnea-hypopnea index, oxyhemoglobin saturation</description>
        <time_frame>6 months after the basal evaluation</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Inflammatory Markers</title>
        <description>Blood samples to test: tumor necrosis factor-alpha (TNF-alpha), C-reactive protein (CRP), Interleukin-6 and Interleukin-8</description>
        <time_frame>6 months after the basal evaluation</time_frame>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sleep Apnea</title>
        <description>Number of events per hour of sleep</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Continuous Positive Airway Pressure (CPAP)</title>
            <description>CPAP is the gold standard treatment
Continuous Positive Airway Pressure (CPAP) : Previously determinated airway pressure: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
          </group>
          <group group_id="O2">
            <title>Oral Appliance</title>
            <description>Alternative treatment for obstructive sleep apnea patients
Oral Appliance (OA) : Anterior mandibular repositioner: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
          </group>
          <group group_id="O3">
            <title>Physical Exercise</title>
            <description>Aerobic and resistance physical exercises
Physical Exercise : aerobic and resistance Physical exercise, three times a week, for four months</description>
          </group>
        </group_list>
        <measure>
          <title>Sleep Apnea</title>
          <description>Number of events per hour of sleep</description>
          <units>number of events</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
                <count group_id="O2" value="9"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.06" spread="10.54"/>
                    <measurement group_id="O2" value="30.76" spread="19.00"/>
                    <measurement group_id="O3" value="22.81" spread="12.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Continuous Positive Airway Pressure (CPAP)</title>
          <description>CPAP is the gold standard treatment
Continuous Positive Airway Pressure (CPAP) : Previously determinated airway pressure: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
        </group>
        <group group_id="E2">
          <title>Oral Appliance</title>
          <description>Alternative treatment for obstructive sleep apnea patients
Oral Appliance (OA) : Anterior mandibular repositioner: used for two months unassociated with physical exercise and used for four months associated with physical exercise</description>
        </group>
        <group group_id="E3">
          <title>Physical Exercise</title>
          <description>Aerobic and resistance physical exercises
Physical Exercise : aerobic and resistance Physical exercise, three times a week, for four months</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="9"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="7"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Teresa Cristina Barros Schutz</name_or_title>
      <organization>Associação Fundo de Incentivo à Pesquisa</organization>
      <phone>55-21-99868033</phone>
      <email>schutzferraz@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

